Who We Are
We’re at the forefront of Psychedelic research and development to contribute innovative solutions for the treatment of mental health disorders.
Shields Pharma Inc. is a privately held science based pharmaceutical and contract testing company committed to advancing treatments focused on how psychedelic medicine can deliver safe, evidence-based solutions to those suffering with pain and mental health disorders such as anxiety, depression, addiction and ADHD.
Shields Pharma Inc. is Health Canada approved organization holding both GMP Drug Establishment License (DEL) (No.: 3-002816-A) and Controlled Substances Dealer’s Licence (No.: 6-1497).
Shields Pharma Inc. is registered with the U.S. Food and Drug Administration. No: 2607599, DUNS No: 20-920-6797, FEI No: 3032623740
Shields Pharma Inc. is a member of PsyCan, The Canadian Psychedelic Businesses Association. Psychedelic Medicine and Therapy Member. Psychedelic Medicine Coalition.